Drug Discovery in France
Searching for the best drug discovery in France? This guide is curated for French businesses and Francophone teams comparing drug discovery across Paris, Lyon, Marseille and the wider French market. Each drug discovery option below is reviewed with RGPD (GDPR) compliance, CNIL guidance, EUR pricing and European data-residency in mind so French buyers can shortlist confidently.
France market snapshot for drug discovery
France is a major European B2B SaaS market with strong demand for sovereign, CNIL-aligned software. Buyers evaluating drug discovery increasingly favour vendors with Paris-region hosting, French-language support and — for sensitive workloads — SecNumCloud-qualified infrastructure.
- Primary language:
- French (Français)
- Business hours:
- Mon–Fri, 09:00–18:00 CET
- Tax label:
- TVA (20%)
- Payment rails:
- SEPA direct debit, credit card, virement bancaire
Buyer's checklist: evaluating drug discovery in France
- Does the drug discovery vendor host data in France or the wider EU/EEA?
- Is a French-language DPA (contrat de sous-traitance) available?
- Does pricing display in EUR with TVA (20%) handled correctly?
- Is French-language support offered during CET business hours?
- For sensitive workloads, does the drug discovery provider hold SecNumCloud or HDS qualifications?
- Are ISO 27001 and CNIL best-practice guidelines documented?
Typical drug discovery pricing for French buyers
Startup / PME
€15–€45 per user
entry drug discovery plans for French startups and small PME
ETI / mid-market
€50–€120 per user
mid-market drug discovery tiers with EU hosting and RGPD DPA
Grand compte
Custom EUR pricing
drug discovery enterprise contracts with SecNumCloud/HDS options and French support
French buyers usually require compliant TVA invoices with SIREN/SIRET fields.
Compliance & regulators
RGPD / GDPR compliance and CNIL guidance. Key regulators referenced when evaluating drug discovery in France:
- CNIL
- ANSSI
- ACPR (for FinTech)
Preferred hosting regions
For low-latency delivery of drug discovery to users in France, buyers typically favour:
- eu-west-3 (Paris)
- eu-central-1 (Frankfurt)
- SecNumCloud-qualified providers (OVHcloud, Outscale)
Procurement notes for French buyers
French procurement teams generally review the DPA against CNIL guidance, run a PIA (analyse d'impact) for higher-risk drug discovery use cases, and check that sub-processors are documented. Expect a 3–6 week evaluation cycle for enterprise drug discovery deployments in France.
Frequently asked by French buyers
How is pricing usually structured for drug discovery in France?
Most drug discovery vendors publish EUR pricing with annual-commitment discounts. French buyers should verify that TVA (20%) is applied correctly, that SIREN/SIRET information appears on invoices and that SEPA direct debit or virement bancaire are supported.
Which certifications matter to French buyers evaluating drug discovery?
ISO 27001 and SOC 2 Type II are baseline expectations. For health data, HDS certification is required, and for sensitive public-sector workloads, SecNumCloud qualification (ANSSI) is a strong differentiator when comparing drug discovery vendors in France.
Which drug discovery platforms are most used by French companies?
French businesses tend to favour drug discovery vendors that offer clear RGPD compliance, EU-hosted infrastructure and EUR-denominated pricing. The shortlist above reflects the drug discovery tools we see adopted most often by teams based in France.
Are these drug discovery tools RGPD (GDPR) compliant for use in France?
Yes — every drug discovery option in this guide is evaluated against RGPD requirements and CNIL best practice, including data processing agreements, sub-processor transparency and EU/EEA hosting. French buyers should still validate each vendor's current DPA before signing.
Do these drug discovery vendors offer French-language support and documentation?
Several of the drug discovery vendors shortlisted maintain French-language interfaces, help centres and support desks — particularly those with a Paris or Lyon presence. Enterprise buyers should confirm French-language SLA coverage during CET business hours.
Related searches from French buyers
- drug discovery alternatives for French PME and ETI
- SecNumCloud drug discovery providers
- drug discovery hébergé en France
- drug discovery conforme RGPD
- drug discovery with French-language support
Content on this page is presented in English for French businesses and Francophone teams. Regional pricing, compliance, hosting and procurement notes reflect what matters most when evaluating drug discovery in France and France and French-speaking Europe.